An important subset of human breast cancer is characterized by over- expression of the epidermal growth factor receptor (EGFR). This sub-group constitutes about 30% of all breast cancers, and over-expression of EGFR has been repeatedly shown to be an indicator of poor prognosis. The overall goal of this grant is to use a novel expression cloning strategy, in conjunction with a unique panel of breast cancer and normal breast epithelial cell lines, to determine the causal molecular alterations that induce specific altered growth phenotypes pf EGFR-positive human breast cancer cells.
The specific aims of this proposal are: 1.) To functionally clone and identify genes from retroviral expression libraries derived from EGFR over-expressing breast cancer cells that induce EGFR- independent proliferation of normal and immortalized human mammary epithelial cells. 2.) To functionally clone and identify genes from retroviral expression libraries derived from EGFR over-expressing breast cancer cells that induce anchorage independent growth capacity in a panel of human mammary epithelial cells with varying abilities to survive in soft agar. 3.) To use differential display PCR, and high density oligonucleotide arrays, to analyze changes in gene expression in growth factor independent or anchorage independent clones isolated in these experiments. High titer retroviral expression libraries will be developed, using HBC cell lines developed in our lab, that over-express EGFR without gene amplification. These cells do not have amplifications of the common breast oncogenes, but do have amplified regions of their genome as determined by comparative genomic hybridization. Retroviral expression libraries will be transduced into a panel of well characterized human mammary epithelial cells, and transformants will be selected on the basis growth factor or anchorage independent growth. Inserts will be rescued by PCR using primers that bind to vector sequences, and then sequenced. This approach will allow us to identify and functionally clone breast cancer oncogenes directly from well characterized human breast cancer cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA077416-02
Application #
6124472
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
Freeman, Colette S
Project Start
1998-12-18
Project End
2002-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
2
Fiscal Year
2000
Total Cost
$215,113
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Berquin, Isabelle M; Pang, Bing; Dziubinski, Michele L et al. (2005) Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells. Oncogene 24:3177-86
Berquin, I M; Dziubinski, M L; Nolan, G P et al. (2001) A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin. Oncogene 20:4019-28